These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

98 related articles for article (PubMed ID: 3717195)

  • 61. Pharmacodynamic comparison of prostaglandin E1 administered by different routes to rats.
    Gu FG; Cui FD; Gao YL
    Yao Xue Xue Bao; 2007 Jul; 42(7):787-93. PubMed ID: 17882966
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Relationship between bioassay and radioimmunoassay estimates of prolactin in rat serum.
    Leung FC; Russell SM; Nicoll CS
    Endocrinology; 1978 Nov; 103(5):1619-28. PubMed ID: 570911
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Effect of the concentration of circulating prolactin on dairy cows' responsiveness to domperidone injection.
    Tong JJ; Thompson IM; Zhao X; Lacasse P
    J Dairy Sci; 2018 Mar; 101(3):2579-2587. PubMed ID: 29331457
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Effect of fenfluramine oral administration on serum prolactin levels in healthy and hyperprolactinemic women.
    Scarduelli C; Mattei AM; Brambilla G; Zavaglia C; Adelasco P; Cavioni V; Ferrari C
    Gynecol Obstet Invest; 1985; 19(2):92-6. PubMed ID: 3988149
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Stimulatory effect of chlorpromazine on prolactin secretion in anencephalic infants.
    Taga M; Minaguchi H; Sakamoto S
    J Clin Endocrinol Metab; 1981 Nov; 53(5):1081-3. PubMed ID: 7287876
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Plasma thyrotropin-releasing hormone, prolactin, thyrotropin, and thyroxine concentrations following the intravenous or oral administration of thyrotropin-releasing hormone.
    Andreassen B; Huth J; Tyson JE
    Am J Obstet Gynecol; 1979 Nov; 135(6):737-42. PubMed ID: 115316
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Early biomarker response and patient preferences to oral and intramuscular vitamin B12 substitution in primary care: a randomised parallel-group trial.
    Metaxas C; Mathis D; Jeger C; Hersberger KE; Arnet I; Walter P
    Swiss Med Wkly; 2017; 147():w14421. PubMed ID: 28421567
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Prolactin response after gonadotropin-releasing hormone in the polycystic ovary syndrome.
    Shoupe D; Lobo RA
    Fertil Steril; 1985 Apr; 43(4):549-53. PubMed ID: 3921411
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Bioavailability of oral vs intramuscular iodinated oil (Lipiodol UF) in healthy subjects.
    Leverge R; Bergmann JF; Simoneau G; Tillet Y; Bonnemain B
    J Endocrinol Invest; 2003; 26(2 Suppl):20-6. PubMed ID: 12762636
    [TBL] [Abstract][Full Text] [Related]  

  • 70. The effect of perphenazine on the level of prolactin in sheep blood.
    McNeilly JR; Lamming GE
    J Endocrinol; 1971 Jun; 50(2):359-60. PubMed ID: 5104494
    [No Abstract]   [Full Text] [Related]  

  • 71. Route and method of delivery of DNA vaccine influence immune responses in mice and non-human primates.
    McCluskie MJ; Brazolot Millan CL; Gramzinski RA; Robinson HL; Santoro JC; Fuller JT; Widera G; Haynes JR; Purcell RH; Davis HL
    Mol Med; 1999 May; 5(5):287-300. PubMed ID: 10390545
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Evidence of antagonism between prolactin and gonadotrophin secretion: effect of methalibure on perphenazine-induced prolactin secretion inovariectomized rats.
    Ben-David M; Danon A; Sulman FG
    J Endocrinol; 1971 Dec; 51(4):719-25. PubMed ID: 5138318
    [No Abstract]   [Full Text] [Related]  

  • 73. Increased prolactin response to thyrotropin-releasing hormone in primary ovarian failure.
    Hochner-Celnikier D; Zylber-Haran E; Shilo S; Palti Z; Spitz IM
    Obstet Gynecol; 1982 Mar; 59(3):280-4. PubMed ID: 6804899
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Interaction of perphenazine with the kinetics of nortriptyline.
    Overo KF; Gram LF; Hansen V
    Acta Pharmacol Toxicol (Copenh); 1977 Jan; 40(1):97-105. PubMed ID: 576367
    [TBL] [Abstract][Full Text] [Related]  

  • 75. [Chronic schizophrenia treated with depot perphenazine].
    Petersson H; Remvig J; Sorensen B
    Nord Psykiatr Tidsskr; 1971; 25(4):303-8. PubMed ID: 5154114
    [No Abstract]   [Full Text] [Related]  

  • 76. Prediction of the optimal perphenazine decanoate dose based on blood samples drawn within the first three weeks.
    Larsen NE; Hansen LB
    Ther Drug Monit; 1989 Nov; 11(6):642-6. PubMed ID: 2595744
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Oral intake of perphenazine decanoate.
    Larsen NE
    Ther Drug Monit; 1998 Dec; 20(6):724. PubMed ID: 9853996
    [No Abstract]   [Full Text] [Related]  

  • 78. Effects of chlorpromazine and perphenazine on bar-pressing performance in an approach-avoidance conflict.
    GROSSMAN SP
    J Comp Physiol Psychol; 1961 Oct; 54():517-21. PubMed ID: 13902303
    [No Abstract]   [Full Text] [Related]  

  • 79. [Perphenazine enantate in long-term therapy of psychoses].
    Gunby B
    Nord Psykiatr Tidsskr; 1968; 22(4):358-60. PubMed ID: 5710606
    [No Abstract]   [Full Text] [Related]  

  • 80. Perphenazine side-effects presenting in oral surgical practice.
    Smith AJ
    Br J Oral Surg; 1973 Mar; 10(3):349-51. PubMed ID: 4516119
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.